NASDAQ
Agios Pharmaceuticals, Inc. (AGIO) has a free cash flow growth of -22.97% as of Friday, May 29, 2026. This represents a 494.04% decrease compared to its 12-month average of 5.83%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.